Sector Chart Spero Therapeutics, Inc. Börse Stuttgart
Stocks
2HA
US84833T1034
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
23:00:34 08/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.021 EUR | -0.78% |
|
-3.02% | -46.01% |
| 08-13 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 74.68B | |||||
| 58.7B | |||||
| 48.36B | |||||
| 43.05B | - | - | - | - | - |
| 42.48B |
Select your edition
All financial news and data tailored to specific country editions
